🇺🇸 FDA

Drug profile · INN

chlordiazepoxide hydrochloride

CHLORDIAZACHEL

approved
US status
approved
Patents linked
3
News articles
0

Quick answer

chlordiazepoxide hydrochloride (CHLORDIAZACHEL) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN chlordiazepoxide hydrochloride
Brand CHLORDIAZACHEL
Route INJECTION
Formulation CAPSULE
Originator Amneal Pharma Europe Ltd

Related patents

Search patents →

  1. US 11484501

    Mechanochemical activated dry amorphisation by milling equilibrium between ap mesoporous silica

    Expires Mon Oct 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11478424

    Mechanochemcial activated dry amorphisation by milling equilibrium between AP mesoporous silica

    Expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 6132724

    Allelic polygene diagnosis of reward deficiency syndrome and treatment

    Expires Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is chlordiazepoxide hydrochloride?

chlordiazepoxide hydrochloride (CHLORDIAZACHEL) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for chlordiazepoxide hydrochloride?

CHLORDIAZACHEL is a marketed brand name for chlordiazepoxide hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of chlordiazepoxide hydrochloride?

chlordiazepoxide hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.